Fingerprint
Dive into the research topics of 'Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
E. Claire Dees, Jeffrey R. Infante, Roger B. Cohen, Bert H. O’Neil, Suzanne F. Jones, Margaret von Mehren, Hadi Danaee, Yih Lee, Jeffrey A. Ecsedy, Mark Manfredi, Katherine Galvin, Bradley Stringer, Hua Liu, Omar Eton, Howard Fingert, Howard A. Burris
- University of North Carolina at Chapel Hill
- Tennessee Oncology PLLC
- Sarah Cannon Research Institute
- University of Pennsylvania
- Fox Chase Cancer Center
- Hospital Clinico Universitario de Valencia
- Departments of Medical Oncology
- University of Texas Health Science Center at San Antonio
- Indiana University-Purdue University Indianapolis
- Takeda Pharmaceutical Company
- Forest Laboratories, Inc
- Boston University
Research output: Contribution to journal › Article › peer-review
67
Scopus
citations